Pacific Medical Solutions Nano PNC Water Recall: Non-sterile Water Risk
Pacific Medical Solutions recalls Nano PNC Water (amber glass bottles, Rx only) due to non-sterility. This product contains variovorax paradoxus, a risk for infections.
Lower-risk recall
Marketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.
Contact the company
What happened, in plain English
Pacific Medical Solutions is recalling Nano PNC Water, which is sold by prescription in amber glass bottles. The product was found to contain variovor: a bacteria that can cause infections, making it unsafe for use. Read more at govinfonow.com/recall/42129-pacific-medical-solutions-nano-pnc-water-recall-non-sterile-water.
Source Summary by GovInfoNow · govinfonow.com/recall/42129-pacific-medical-solutions-nano-pnc-water-recall-non-sterile-water · Updated October 8, 2026 · FDA enforcement record: FDA #D-0505-2017
Cite this page
“Pacific Medical Solutions Nano PNC Water Recall: Non-sterile Water Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42129-pacific-medical-solutions-nano-pnc-water-recall-non-sterile-water. Based on FDA recall #D-0505-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0505-2017%22&limit=1).
Why it’s dangerous
The product was found to contain variovorax paradoxus, a type of bacteria. This can lead to infections, especially in people with weakened immune systems.
Who’s affected
People who have been prescribed Nano PNC Water by a doctor are affected. Those with compromised immune systems may be at higher risk.
How to tell if you have this one
Look for Nano PNC Water in amber glass bottles sold by prescription. The product is part of the Immune Cellular Restoration Program and available through ICRPstudy.com.
- Brand
Pacific Medical Solutions- Category
Drug
What to do — step by step
Check Product Label
Look for the product name 'Nano PNC Water' on the label, which is packaged in amber glass bottles and sold by prescription.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Nationwide in the United States and Mexico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 3 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0505-2017 (December 13, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0505-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.